Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended versus standard prednisolone for first-episode childhood steroid-sensitive nephrotic syndrome
2010-022489-29Phase 3Completed
- Sponsor
- University of Birmingham
- Start
- Nov 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prednisolone in nephrosis (2 arms), sponsored by University of Birmingham. Primary endpoint: Time to first relapse. Started Nov 2010; status: completed.
02
Drugs
prednisolone
03
Conditions
nephrosis
Beyond the preview
Go deeper on 2010-022489-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022489-29.